Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Royal Bancshares Chairman, CEO Robert Tabas Plans To Retire By 2012-end

Royal Bancshares of Pennsylvania, Inc. (RBPAA: Quote) said Robert Tabas, chairman and chief executive officer, plans to retire by the end of 2012. Tabas will remain chairman of the board of directors.

The company's board of directors has formed a search committee to select an executive search firm and interview candidates for the combined role of president and chief executive officer.

Murray Stempel, vice chairman and chief lending officer, will also retire from active management of the company and as vice chairman by the end of the year but will remain on the company's board of directors. Further, James McSwiggan has advised the board of his decision to retire as president and chief operating officer and to step down from the board on or before December 31, 2012.

Click here to receive FREE breaking news email alerts for Royal Bancshares Of Pennsylvania Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.